Befotertinib(1835667-63-4)名称与标识符
名称
英文别名:
0XT2CPR891;Befotertinib;Befotertinib [INN];2-Propenamide, N-(2-((2-(dimethylamino)ethyl)methylamino)-4-methoxy-5-((4-(1-(2,2,2-trifluoroethyl)-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)-;N-(2-((2-(Dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-(2,2,2-trifluoroethyl)-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)prop-2-enamide;Unii-0XT2cpr891;MS-30266;1835667-63-4;N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-(2,2,2-trifluoroethyl)-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide;Befotertinib [WHO-DD];D0316;Surmana;GLXC-26863;compound 4 [WO2019218987A1];N-[2-[2-(dimethylamino)ethyl-methylamino]-4-methoxy-5-[[4-[1-(2,2,2-trifluoroethyl)indol-3-yl]pyrimidin-2-yl]amino]phenyl]prop-2-enamide;HY-137433;DA-71363;GTPL12951;AKOS040757081;D-0316;compound 4 (WO2019218987A1);D 0316;SCHEMBL19337178;USOCZVZOXKTJTI-UHFFFAOYSA-N;D-0316 [WHO-DD];CS-0138633;F78035;CHEMBL5095167;N-(2-(2-(dimethylamino)ethyl-methylamino)-4-methoxy-5-((4-(1-(2,2,2-trifluoroethyl)indol-3-yl)pyrimidin-2-yl)amino)phenyl)prop-2-enamide;
标识符
InChIKey:
USOCZVZOXKTJTI-UHFFFAOYSA-N
Inchi:
1S/C29H32F3N7O2/c1-6-27(40)34-22-15-23(26(41-5)16-25(22)38(4)14-13-37(2)3)36-28-33-12-11-21(35-28)20-17-39(18-29(30,31)32)24-10-8-7-9-19(20)24/h6-12,15-17H,1,13-14,18H2,2-5H3,(H,34,40)(H,33,35,36)
SMILES:
FC(CN1C=C(C2C=CN=C(N=2)NC2=CC(=C(C=C2OC)N(C)CCN(C)C)NC(C=C)=O)C2C=CC=CC1=2)(F)F